- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Database
- September 2024
Global
€1800EUR$2,028USD£1,565GBP
- Report
- November 2024
- 22 Pages
Europe
€1658EUR$1,868USD£1,442GBP
- Database
- October 2024
Global
€2800EUR$3,155USD£2,435GBP
- Report
- May 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 201 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- February 2025
- 211 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Directory
- January 2025
- 80 Pages
Global
- Report
- December 2020
- 63 Pages
Germany
From €554EUR$604USD£450GBP
- Report
- January 2024
- 65 Pages
Latin America
€2128EUR$2,398USD£1,850GBP
- Report
- September 2022
- 290 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2024
- 125 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- February 2024
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2021
- 200 Pages
Global
From €3969EUR$4,175USD£3,334GBP
- Report
- August 2023
- 118 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 140 Pages
Europe
From €3803EUR$4,000USD£3,195GBP
- Report
- February 2024
- 130 Pages
Global
From €4516EUR$4,750USD£3,794GBP

The recreational cannabis market has become a notable segment within the broader analgesics industry, as consumers increasingly seek alternatives to traditional over-the-counter and prescription pain relievers. Cannabis is touted for its pain-relieving properties, with THC and CBD being the most prominent constituents associated with analgesic effects. Recreational cannabis offers a dual benefit of alleviating pain and providing a pleasurable experience, which has led to its rising popularity where it is legally permitted. It is available in various forms, including but not limited to flower, edibles, oils, and topicals. Consumers can choose products based on desired effect, potency, and mode of consumption. The market's expansion is further driven by ongoing research and development aimed at understanding the therapeutic potential of cannabis and optimizing its use for pain management.
Several companies have established their presence in the recreational cannabis market with a focus on analgesic products. Well-known players include Canopy Growth Corporation, Aurora Cannabis, and Tilray, all of which have extensive product lines and international reach. Other notable companies are Curaleaf and Cresco Labs, which have a strong presence in the United States. These companies are engaged in competitive strategies, including product innovation and mergers & acquisitions, to capture a larger share of the market. Show Less Read more